Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Net Sales
639.13
456.27
Other Operating Income
0.00
0.00
Total Operating income
639.13
456.27
Raw Material Cost
485.84
323.98
Purchase of Finished goods
0.00
0.00
(Increase) / Decrease In Stocks
-31.69
6.05
Employee Cost
39.30
22.23
Power Cost
0.00
0.00
Manufacturing Expenses
15.66
17.56
Selling and Distribution Expenses
0.00
0.00
Other Expenses
41.83
31.54
Total Expenditure (Excl Depreciation)
550.94
401.36
Operating Profit (PBDIT) excl Other Income
88.19
54.91
Other Income
0.00
0.00
Operating Profit (PBDIT)
88.19
54.91
Interest
32.94
22.38
Exceptional Items
0.00
0.00
Gross Profit (PBDT)
55.25
32.53
Depreciation
8.25
5.04
Profit Before Tax
47.00
27.49
Tax
14.38
7.75
Provisions and contingencies
0.00
0.00
Profit After Tax
32.62
19.74
Extraordinary Items
0.00
0.00
Prior Period Expenses
0.00
0.00
Other Adjustments
0.00
0.00
Net Profit
32.62
19.74
Share in Profit of Associates
0.00
0.00
Minority Interest
0.00
0.00
Other related items
0.00
0.00
Consolidated Net Profit
32.62
19.74
Equity Capital
5.47
4.72
Face Value
10.0
10.0
Reserves
272.64
136.68
Earnings per share (EPS)
59.63
41.82
Diluted Earnings per share
61.23
44.83
Operating Profit Margin (Excl OI)
13.92%
12.16%
Gross Profit Margin
8.72%
7.2%
PAT Margin
5.15%
4.37%
Public Share Holdings (%)
55.83%
51.07%
Pledged Promotor Holding (%)
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 40.21% vs 30.33% in Mar 2025
Standalone Net Profit
YoY Growth in year ended Mar 2026 is 59.59% vs 33.23% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 72.05% vs 41.65% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 75.60% vs 63.96% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has improved from Mar 2025
Compare Annual Results Of Fredun Pharma With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
639.13
231.70
407.43
175.84%
Other Operating Income
0.00
2.88
-2.88
-100.00%
Total Operating income
639.13
234.59
404.54
172.45%
Raw Material Cost
485.84
72.83
413.01
567.09%
Purchase of Finished goods
0.00
15.68
-15.68
-100.00%
(Increase) / Decrease In Stocks
-31.69
-1.93
-29.76
-1,541.97%
Employee Cost
39.30
33.58
5.72
17.03%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
15.66
37.41
-21.75
-58.14%
Selling and Distribution Expenses
0.00
37.38
-37.38
-100.00%
Other Expenses
41.83
10.61
31.22
294.25%
Total Expenditure (Excl Depreciation)
550.94
205.57
345.37
168.01%
Operating Profit (PBDIT) excl Other Income
88.19
29.02
59.17
203.89%
Other Income
0.00
4.83
-4.83
-100.00%
Operating Profit (PBDIT)
88.19
33.85
54.34
160.53%
Interest
32.94
0.43
32.51
7,560.47%
Exceptional Items
0.00
2.69
-2.69
-100.00%
Gross Profit (PBDT)
55.25
36.11
19.14
53.00%
Depreciation
8.25
2.87
5.38
187.46%
Profit Before Tax
47.00
33.24
13.76
41.40%
Tax
14.38
12.10
2.28
18.84%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
32.62
21.14
11.48
54.30%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
32.62
21.14
11.48
54.30%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
32.62
21.14
11.48
54.30%
Equity Capital
5.47
2.92
2.55
87.33%
Face Value
10.00
2.00
0.00
Reserves
272.64
0.00
272.64
Earnings per share (EPS)
59.63
7.23
52.40
724.76%
Diluted Earnings per share
61.23
14.47
46.76
323.15%
Operating Profit Margin (Excl OI)
13.92%
12.37%
0.00
1.55%
Gross Profit Margin
8.72%
15.39%
0.00
-6.67%
PAT Margin
5.15%
9.01%
0.00
-3.86%
Public Share Holdings (%)
55.83%
0.00%
55.83
55.83%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 633.33 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 40.21% vs 30.33% in Mar 2025
Annual - Standalone Net Profit
Standalone Net Profit 33.21 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 59.59% vs 33.23% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 94.80 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 72.05% vs 41.65% in Mar 2025
Annual - Interest
Interest 39.30 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 75.60% vs 63.96% in Mar 2025
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.97%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has improved from Mar 2025
